Berlin Cures, a biotechnology firm specializing in the neutralization of functional autoantibodies, is extending its collaboration with Uniklinikum Erlangen in the fight against Long COVID.
Berlin Cures, a biotechnology firm specializing in the neutralization of functional autoantibodies, is extending its collaboration with Uniklinikum Erlangen in the fight against Long COVID.